Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Ifosfamide in Hematological Malignancies of Adults
View through CrossRef
Ifosfamide is an alkylating agent with a broad spectrum of activity in solid tumors and hematological malignancies. In this review we will illustrate its use in the treatment of lymphomas and Hodgkin’s disease and the results of the principal studies which have investigated ifosfamide-containing regimens. Ifosfamide has been mainly used, in combination with other drugs, as a component of salvage regimens for relapsed or primarily refractory lymphoma. These regimens induced a variable clinical response rate (complete remissions ranging from 6 up to 73% and overall response rate from 24 to 72%). High-dose ifosfamide, in combination with etoposide or mitoxantrone, showed a good potential for mobilization of peripheral stem cells while reducing the tumor burden. Ifosfamide-based regimens are also being evaluated in the treatment of newly diagnosed patients in sequential, response-based protocols, using many non-cross-resistant drugs.
Title: Ifosfamide in Hematological Malignancies of Adults
Description:
Ifosfamide is an alkylating agent with a broad spectrum of activity in solid tumors and hematological malignancies.
In this review we will illustrate its use in the treatment of lymphomas and Hodgkin’s disease and the results of the principal studies which have investigated ifosfamide-containing regimens.
Ifosfamide has been mainly used, in combination with other drugs, as a component of salvage regimens for relapsed or primarily refractory lymphoma.
These regimens induced a variable clinical response rate (complete remissions ranging from 6 up to 73% and overall response rate from 24 to 72%).
High-dose ifosfamide, in combination with etoposide or mitoxantrone, showed a good potential for mobilization of peripheral stem cells while reducing the tumor burden.
Ifosfamide-based regimens are also being evaluated in the treatment of newly diagnosed patients in sequential, response-based protocols, using many non-cross-resistant drugs.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract
Introduction
Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
Ifosfamide-induced Nephrotoxicity in Children: Critical Review of Predictive Risk Factors
Ifosfamide-induced Nephrotoxicity in Children: Critical Review of Predictive Risk Factors
Ifosfamide is widely used in the treatment of pediatric solid tumors. Its main adverse effects are various forms of renal tubular and glomerular damage. Many risk factors have been...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Neuron-Specific Enolase as a Biomarker in Ifosfamide-Induced Encephalopathy: A Case Report
Neuron-Specific Enolase as a Biomarker in Ifosfamide-Induced Encephalopathy: A Case Report
Introduction: Ifosfamide, an alkylating agent, is used in treatment of various malignancies and may cause encephalopathies. The pathophysiology of this treatment adverse event is w...
Iron Overload after Hematopoietic Stem Cell Transplantation
Iron Overload after Hematopoietic Stem Cell Transplantation
Abstract
Introduction Iron overload (IOL) is a common complication after HSCT, mainly due to iterative red blood cell (RBC) transfusions with other mechanisms as ine...
Machine learning and traditional analysis of the interaction between cardiovascular diseases and hematological malignancies
Machine learning and traditional analysis of the interaction between cardiovascular diseases and hematological malignancies
Abstract
Background
Cardiovascular diseases and clonal hematopoiesis of indetermine potential (CHIP), the premalignant state of ...
Treatment of Invasive Thymoma With Single-Agent Ifosfamide
Treatment of Invasive Thymoma With Single-Agent Ifosfamide
PURPOSE: To evaluate single-agent ifosfamide in the treatment of invasive thymoma. PATIENTS AND METHODS: Fifteen patients (eight male and seven female) with histologically confirm...